Vera Therapeutics, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
VERA on Nasdaq
Location
2000 Sierra Point Parkway, Suite 1200, Brisbane, CA

Insiders trading volume in the past year

Vera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Maha Katabi Director $113M -$29.1M -20.5% May 15, 2024
Commodore Capital Lp 10%+ Owner $79.2M -$18.9M -19.3% Jan 10, 2024
Sofinnova Venture Partners X, L.P. 10%+ Owner $62.4M Feb 6, 2023
Kurt Von Emster Director $53.6M May 17, 2021
Carlyle Group Inc. 10%+ Owner $53.3M Aug 17, 2022
Abingworth LLP 10%+ Owner $53.3M May 13, 2021
Longitude Capital Partners IV, LLC 10%+ Owner $30.9M Feb 6, 2023
Longitude Prime Partners, LLC 10%+ Owner $30.9M Feb 6, 2023
Marshall Fordyce PRESIDENT AND CEO, Director $15.1M -$6.83M -31.1% Nov 13, 2024
Beth C. Seidenberg Director $6.72M -$1.42M -17.4% Oct 28, 2024
Sean Grant Chief Financial Officer $2.8M -$4.69M -62.6% Apr 3, 2024
Jason S. Carter Chief Legal Officer $2.6M Nov 18, 2024
Joseph R. Young Svp, Finance, Chief Acct Offcr $2.2M -$1.53M -41% May 15, 2024
Joanne Curley Chief Development Officer $485K Aug 21, 2023
Celia Lin Chief Medical Officer $198K Aug 21, 2023
Christy J. Oliger Director $129K Jun 7, 2024
David Lee Johnson Chief Operating Officer Jul 1, 2024
Robert Brenner Chief Medical Officer Jan 3, 2024
Andrew Cheng Director May 15, 2024
Jonathan Wolter Chief Financial Officer May 13, 2021
Kimball Hall Director May 15, 2024
Scott W. Morrison Director May 15, 2024
Patrick G. Enright Director May 15, 2024
William D. Turner Chief Development Officer Jan 5, 2024
Ares Trading S.A. 10%+ Owner May 13, 2021
Michael Morrissey Director May 15, 2024

Recent Insider Transactions by Companies or Individuals for Vera Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.